Vanguard Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.71M | Buy |
120,869
+6,851
| +6% | +$323K | ﹤0.01% | 3168 |
|
|
2025
Q1 | $4.45M | Sell |
114,018
-1,398
| -1% | -$54.6K | ﹤0.01% | 3224 |
|
|
2024
Q4 | $6.25M | Sell |
115,416
-2,320
| -2% | -$126K | ﹤0.01% | 3176 |
|
|
2024
Q3 | $5.94M | Buy |
117,736
+25,896
| +28% | +$1.31M | ﹤0.01% | 3201 |
|
|
2024
Q2 | $4.04M | Sell |
91,840
-458
| -0.5% | -$20.1K | ﹤0.01% | 3346 |
|
|
2024
Q1 | $4.64M | Buy |
92,298
+18,641
| +25% | +$936K | ﹤0.01% | 3327 |
|
|
2023
Q4 | $4.45M | Buy |
73,657
+60,066
| +442% | +$3.63M | ﹤0.01% | 3336 |
|
|
2023
Q3 | $775K | Buy |
+13,591
| New | +$775K | ﹤0.01% | 3922 |
|